FIELD: medicine, hematology, pharmacology.
SUBSTANCE: invention relates to an agent influencing on blood rheology and aggregation of platelets. Invention proposes applying bis-[3-(3,5-di-tert.-butyl-4-hydroxyphenyl)propyl]-sulfide known early as a semiproduct used in preparing biotin as a hemorheological and anti-thrombosis agent. Invention expands assortment of agents eliciting hemorheological and anti-thrombosis properties simultaneously.
EFFECT: valuable medicinal properties of agent.
2 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| REMEDY HAVING ANTIAGGREGANT ACTIVITY, ACTIVITY DECREASING BLOOD HYPERVISCOSITY AND ANTITHROMBOGENIC ACTIVITY | 2008 |
|
RU2368376C1 |
| HEMORHEOLOGICAL AND ANTITHROMBOTIC AGENT | 2003 |
|
RU2239423C1 |
| AGENTS WITH HEMORHEOLOGICAL, ANTIAGGREGANT AND ANTITROMBOGENIC ACTIVITY | 2007 |
|
RU2347561C2 |
| AGENT POSSESSING HEMORGHEOLOGICAL AND ANTIPLATELET ACTIVITY | 2007 |
|
RU2342944C1 |
| DRUG WITH COMPLEX PHARMACOLOGICAL EFFECT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CORRECTION OF CEREBRAL CIRCULATION DISORDERS, TREATMENT OF CONSEQUENCES OF CEREBROVASCULAR DISEASES (OPTIONS) | 2019 |
|
RU2757874C1 |
| MEDICATION FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2014 |
|
RU2555335C9 |
| AGENT POSSESSING ANTIAGGREGANT ACTIVITY | 2019 |
|
RU2696583C1 |
| USING SECOISOLARICIRESINOL AS HAEMORHEOLOGICAL, ANTI-PLATELET AND ENDOTHELIUM-PROTECTIVE AGENT | 2013 |
|
RU2532356C1 |
| 2-(3,4-DIHYDROXYPHENYL)-9-DIETHYLAMINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE DIHYDROBROMIDE AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2391979C2 |
| DICALCIUM SALT OF N-(3-HYDROXYBENZOYL)TAURINE, HAVING ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY IN COMBINATION WITH CEREBROPROTECTIVE ACTION | 2019 |
|
RU2730835C1 |
